Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 78 600 KRW -0.25% Market Closed
Market Cap: 1.1T KRW

Chong Kun Dang Pharmaceutical Corp's latest stock split occurred on Dec 27, 2024

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Chong Kun Dang Pharmaceutical Corp traded at 93900.0003 per share. Afterward, the share price was about 87500.

The adjusted shares began trading on Dec 27, 2024. This was Chong Kun Dang Pharmaceutical Corp's 8th stock split, following the previous one in Dec 27, 2023.

Last Splits:
Dec 27, 2024
1-for-1
Dec 27, 2023
1-for-1
Dec 28, 2022
1-for-1
Dec 29, 2021
1-for-1
Dec 29, 2020
1-for-1
Pre-Split Price
89 428.5717 93 900.0003
Post-Split Price
87 500
Before
After
Last Splits:
Dec 27, 2024
1-for-1
Dec 27, 2023
1-for-1
Dec 28, 2022
1-for-1
Dec 29, 2021
1-for-1
Dec 29, 2020
1-for-1

Chong Kun Dang Pharmaceutical Corp
Stock Splits History

Chong Kun Dang Pharmaceutical Corp Stock Splits Timeline
Dec 27, 2024
Dec 27, 2024
Split 1-for-1
/1
Pre-Split Price
89 428.5717 93 900.0003
Post-Split Price
87 500
Before
After
Dec 27, 2023
Dec 27, 2023
Split 1-for-1
/1
Pre-Split Price
120 079.0177 133 599.867
Post-Split Price
126 666.667
Before
After
Dec 28, 2022
Dec 28, 2022
Split 1-for-1
/1
Pre-Split Price
76 694.9585 90 699.8192
Post-Split Price
76 127.9401
Before
After
Dec 29, 2021
Dec 29, 2021
Split 1-for-1
/1
Pre-Split Price
96 556.1439 120 999.638
Post-Split Price
95 551.6022
Before
After
Dec 29, 2020
Dec 29, 2020
Split 1-for-1
/1
Pre-Split Price
164 156.853 216 999.3652
Post-Split Price
172 763.6789
Before
After
Dec 27, 2019
Dec 27, 2019
Split 1-for-1
/1
Pre-Split Price
69 740.5485 97 699.7207
Post-Split Price
71 109.4202
Before
After
Dec 27, 2018
Dec 27, 2018
Split 1-for-1
/1
Pre-Split Price
72 407.3618 107 499.6997
Post-Split Price
73 880.7244
Before
After
Feb 5, 2018
Feb 5, 2018
Split 1-for-1
/1
Pre-Split Price
93 014.9013 144 999.4501
Post-Split Price
92 614.0674
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

Chong Kun Dang Pharmaceutical Corp
Glance View

Market Cap
1T KRW
Industry
Pharmaceuticals

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Intrinsic Value
80 623.92 KRW
Undervaluation 3%
Intrinsic Value
Price
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 250,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.